...
首页> 外文期刊>International Journal of Biomedical and Advance Research >A CROSS-SECTIONAL STUDY TO DETERMINE THE PROFILE AND ANTIBIOTIC RESISTANCE PATTERN OF GRAM NEGATIVE BACILLI ISOLATED FROM INTENSIVE CARE UNIT PATIENTS IN A TERTIARY CARE HOSPITAL IN AHMEDNAGAR, MAHARASHTRA
【24h】

A CROSS-SECTIONAL STUDY TO DETERMINE THE PROFILE AND ANTIBIOTIC RESISTANCE PATTERN OF GRAM NEGATIVE BACILLI ISOLATED FROM INTENSIVE CARE UNIT PATIENTS IN A TERTIARY CARE HOSPITAL IN AHMEDNAGAR, MAHARASHTRA

机译:横断面研究确定从密苏里州艾哈迈德加尔市高等护理医院重症监护病房患者体内分离到的革兰氏阴性杆菌的外形和抗药性

获取原文

摘要

The present study was conducted to track down commonest gram negative bacilli along with their pattern of resistance to antibiotics from various clinical specimens, from patients admitted to intensive care unit. A total of 182 clinical specimens were analyzed using standard techniques. Out of 182 specimens 105 were culture positive, whereas the remaining 77 were culture negative.?? From 105 culture positive specimens 65 (61.90%) showed growth of gram negative bacilli, remaining 40 (38.09%) with growth of gram positive organisms. In this study E .coli was found to be the predominant isolate with 44.61% rate of isolation, followed by Klebsiella pneumoniae 15.38%, rate of isolation of?? Proteus mirabilis, Citrobacter fruendii each accounting for 9.23%. Pseudomonas aeruginosa 7.69%, Proteus vulgaris 3.07%, Acinetobacter species and Salmonella typhi accounted for 1.53 % each. To conclude, aerobic gram negative bacilli were predominant clinical isolates from patients admitted to intensive care unit. Amikacin and gentamicin were found to be effective antibiotics against gram negative bacilli in this particular setting "
机译:进行本研究是为了追踪最常见的革兰氏阴性杆菌及其对重症监护病房各种临床标本对抗生素的耐药模式。使用标准技术对总共182个临床标本进行了分析。在182个标本中,有105个是培养阳性,而其余的77个是培养阴性。从105个培养阳性样本中,有65个(61.90%)显示出革兰氏阴性杆菌的生长,其余40个(38.09%)随着革兰氏阳性菌的生长。在这项研究中,发现大肠杆菌是主要分离株,分离率为44.61%,其次是肺炎克雷伯菌,分离率为15.38%。变形杆菌,弗氏柠檬酸杆菌各占9.23%。铜绿假单胞菌为7.69%,寻常变形杆菌为3.07%,不动杆菌属和伤寒沙门氏菌分别占1.53%。总之,有氧革兰氏阴性杆菌是重症监护病房患者的主要临床分离株。在这种特殊情况下,发现丁胺卡那霉素和庆大霉素是有效的抗革兰氏阴性杆菌的抗生素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号